Breaking
Secure Stock Strategies
Author

admin

Browsing
Politics

‘Absolutely incredible’: B-2 bomber, F-35 escort set stage for Trump-Putin talks in Alaska

As President Donald Trump greeted Russian President Vladimir Putin on the tarmac at Joint Base Elmendorf-Richardson, a B-2 stealth bomber soared overhead, flanked by four F-35 jets. 

Putin looked up at the sky as the planes buzzed overhead while he walked alongside Trump, and then made a comment to the U.S. president. 

The display was as much a symbol as it was a show of force—a pointed reminder of America’s military reach at the very moment the two leaders prepared to discuss the future of global security.

The dramatic arrival underscored the high-stakes nature of the Alaska summit, the first face-to-face meeting between Trump and Putin since Trump’s return to the White House earlier this year. Joint Base Elmendorf-Richardson, situated just outside Anchorage, was chosen for its robust security, strategic location, and symbolic position—physically closer to Russia than Washington, D.C., yet firmly on American soil.

Onlookers in Anchorage and across social media quickly seized on the moment. Many called it an ‘insane flex,’ noting the B-2 bomber’s recent combat history.

Only two months ago, the stealth aircraft played a central role in U.S. and Israeli strikes on Iranian nuclear facilities, dropping bunker-buster bombs in a move that drew both praise and condemnation on the world stage.

The B-2 Spirit, built by Northrop Grumman, is one of the most advanced aircraft ever created—capable of penetrating dense air defenses and striking targets anywhere in the world without refueling. Its distinctive flying-wing design and radar-absorbent coating make it nearly invisible to enemy radar. 

With a range of over 6,000 nautical miles and the ability to carry both conventional and nuclear weapons, the B-2 serves as a critical component of America’s nuclear triad. Only 21 were ever built, and fewer than 20 remain in service, making any public appearance a rare and deliberate statement.

‘Absolutely incredible,’ wrote one X user. Another added, ‘Putin now knows what will be greeting him if he were to ever cross that line that should never be crossed.’

After the brief tarmac ceremony, Putin entered ‘The Beast’ alongside Trump. The heavily armored presidential limousine rolled past a row of American fighter jets lined up in silent formation, their presence another visual reminder of the stakes surrounding the talks.

The two leaders traveled to a secure meeting hall on the base, beginning discussions at about 3:30 p.m. Eastern Time. Trump has said he plans to ‘set the table’ during the meeting for a future summit that includes Ukrainian President Volodymyr Zelenskyy. But still, he told Fox News’ Bret Baier he ‘won’t be happy’ if Putin does not agree to a ceasefire in Ukraine. 

This post appeared first on FOX NEWS

Keep Reading
By
Politics

Zelenskyy to meet with Trump in Washington, DC following US-Russia talks

Ukrainian President Volodymyr Zelenskyy said on Saturday he will travel to Washington, D.C. on Monday to meet with President Donald Trump.

Zelenskyy’s announcement comes a day after Trump met with Russian President Vladimir Putin in Alaska on Friday to negotiate an end to the war in Ukraine.

‘On Monday, I will meet with President Trump in Washington, D.C., to discuss all of the details regarding ending the killing and the war. I am grateful for the invitation,’ Zelenskyy wrote on X.

This is a breaking news story. Check back for updates.

This post appeared first on FOX NEWS

Keep Reading
By
Investing

Crypto Market Update: Bitcoin’s New High, Ethereum ETFs Outpace Bitcoin 5-to-1

Here’s a quick recap of the crypto landscape for Wednesday (August 15) as of 9:00 a.m. UTC.

Get the latest insights on Bitcoin, Ethereum and altcoins, along with a round-up of key cryptocurrency market news.

Bitcoin and Ethereum price update

Bitcoin (BTC) was priced at US$117,981, following a volatile 24 hours. Its lowest valuation of the day was US$117,547, while its highest so far was US$119,315.

Bitcoin price performance, August 15, 2025.

Chart via TradingView

Bitcoin surged to a new all-time high of $124,533 on Thursday (August 14), driven by expectations of Federal Reserve rate cuts and increased institutional interest. However, the rally was short-lived, as the price fell as low as $117,263 early Friday.

The decline was attributed to a higher-than-expected US Producer Price Index (PPI) for July, which dampened investor optimism about imminent interest rate reductions. Additionally, comments from US Treasury Secretary Scott Bessent revealed that the US holds fewer Bitcoin reserves than previously thought, further unsettling the market.

Meanwhile, Ethereum’s (ETH) weekend rally briefly has worn off, currently down by 3 percent to US$4,556.55. The cryptocurrency’s lowest valuation on Friday was US$4,462.52, and its highest was US$4,690.57.

Altcoin price update

  • Solana (SOL) was priced at US$189.85, down by 4.3 percent over 24 hours. Its highest valuation of the day was at US$198.27, while its lowest valuation was US$188.80.
  • XRP was trading for US$3.08, down 1.7 percent in the past 24 hours. Its highest valuation of the day was at US$3.14, while its lowest was US$3.04.
  • Sui (SUI) was trading at US$3.75, down by 2.53 percent over the past 24 hours. Its highest valuation of the day was at US$3.78, while its lowest was US$3.68.
  • Cardano (ADA) was trading at US$0.9485, up by 1.7 percent over 24 hours. Its highest valuation of the day was at US$0.9605, while its lowest was US$0.9362.

Today’s crypto news to know

Ethereum ETFs cruise past Bitcoin, totals nearly US$3 billion in a week

Ethereum-focused exchange-traded funds have seen an unprecedented surge in investor demand, attracting almost US$3 billion in net inflows over the past week.

According to SoSoValue data, this growth is more than five times the US$562 million that flowed into Bitcoin ETFs during the same period. The spike coincides with a rapid increase in Ethereum holdings by crypto treasury firms, which climbed from US$600 million to US$11 billion in just six weeks.

ETF Store president Nate Geraci noted that three of the four largest single-day inflows for Ethereum ETFs since their inception occurred this week alone.

ETH prices have rallied nearly 19 percent over the past seven days, coming within reach of their 2021 all-time high of US$4,878.

The inflows also follow recent SEC approval of in-kind creations and redemptions for spot Bitcoin and Ethereum ETFs, a change that makes the funds more cost-efficient and attractive to institutional investors.

Michael Saylor bets on US$100 billion ‘bitcoin credit’

Michael Saylor, executive chairman of Strategy (NASDAQ:MSTR) (formerly MicroStrategy), is pursuing a high-risk plan to finance further Bitcoin purchases through perpetual preferred stock offerings.

The new securities—nicknamed “Stretch”—do not mature, lack voting rights, and can skip dividends under certain conditions, giving the issuer flexibility while raising investor concerns about risk.

This marks a departure from the company’s earlier reliance on common stock sales and convertible bonds to fund what is now a US$75 billion Bitcoin treasury. Saylor aims to retire billions in outstanding debt and replace it with preferred equity, which he says could theoretically scale to US$100 billion or more in capital raised.

The model hinges on investor appetite for yield backed indirectly by Bitcoin’s performance, while avoiding the dilution impact of issuing more common stock.

Hong Kong SFC rolls out stricter rules for licensed Crypto platforms

Hong Kong’s Securities and Futures Commission (SFC) has introduced new custody rules for licensed virtual asset trading platforms, setting stricter benchmarks for how client assets must be stored and secured.

The updated framework includes specific requirements for cold wallet usage, senior management accountability, and real-time cyber-threat monitoring, alongside rules for using third-party wallet providers.

These measures follow an SFC review earlier this year that identified security and operational gaps among some licensed exchanges. The regulator says the changes are part of its ASPIRe strategy, a five-point plan to address liquidity fragmentation, regulatory arbitrage, and volatility while expanding regulated product offerings.

The policy also aims to position Hong Kong as a safer, more structured alternative to other Asian crypto hubs, notably Singapore, which has imposed tighter limits on retail trading.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Keep Reading
By
Investing

Top 5 Small-cap Pharma Stocks of 2025

Today’s pharmaceutical stocks are facing the challenges of government-imposed drug price caps, waning demand for COVID-19 vaccines and global stock market upheaval. However, the industry’s major underlying drivers — higher rates of cancer and chronic disease — are still at play and not expected to dissipate.

The US reigns supreme in the pharma market, both in terms of drug demand and development. In 2024, 50 novel medicines were approved by the US Food and Drug Administration (FDA), compared to 55 such approvals in 2023. Last year’s FDA approvals include Eli Lilly and Company’s (NYSE:LLY) Alzheimer’s disease treatment Kisunla.

Big pharma largely steals the show, but some small- and mid-cap NASDAQ pharma stocks have also made gains.

Read on to learn more about their activities this year.

1. ABVC BioPharma (NASDAQ:ABVC)

Year-to-date gain: 405.95 percent
Market cap: US$50.61 million
Share price: US$2.98

ABVC BioPharma is a clinical-stage biopharma firm building a pipeline of products targeting a broad range of indications in ophthalmology, oncology, hematology and central nervous system (CNS) disorders.

It is advancing on six drugs and one medical device. ABVC in-licenses biotechnologies from research institutions such as Stanford University, the University of California at San Francisco and Cedars-Sinai Medical Center.

In mid-April, ABVC reported its 2024 financial results, highlighting total revenues of US$509,589 in 2024, representing 234 percent growth year-on-year. The company attributed this increase to milestone payments collected from its global licensing partners in the CNS, oncology and ophthalmology therapeutic areas.

This positive news provided a good base of support for ABVC’s share price, which started the year out at US$0.64, but by the end of April had pushed through the US$1 level.

Developments later in the summer gave the stock a further boost to the upside. On June 6, ABVC announced that its affiliate OncoX BioPharma is set to acquire the Lycopenoid Lycogen platform, including patented manufacturing technology and commercialization rights, from Asia-Pacific Biotech Developing.

‘OncoX’s acquisition of the Lycogen platform further enhances ABVC Group’s position in botanical oncology innovation,’ said ABVC CEO Dr. Uttam Patil in a press release at the time. ‘This transaction strengthens our pipeline and demonstrates our ability to convert platform assets into monetizable growth.’

In July, ABVC received a US$150,000 cash licensing payment from AiBtl BioPharma, one of its strategic partners. It represents a key milestone toward the company’s commercialization of its drug candidates ABV-1504 and ABV-1505, which are now under late-stage development for major depressive disorder and ADHD, respectively. Both of these drug candidates have active investigational new drug designations from the FDA.

That same month, the company received a US$100,000 milestone licensing payment from its licensing partner ForSeeCon Eye, which is working to develop and commercialize drugs for ophthalmic indications. This brought its cumulative licensing revenue across its strategic partnerships with AiBtl, OncoX and ForSeeCon to US$946,000.

Shares of ABVC reached a year-to-date high of US$4.74 on July 8.

2. I-Mab (NASDAQ:IMAB)

Year-to-date gain: 282.35 percent
Market cap: US$231.3 million
Share price: US$3.37

I-Mab is a global biotech firm developing precision immuno-oncology agents for the treatment of cancer.

The company’s lead candidate in its drug pipeline is givastomig, a bispecific antibody designed to treat Claudin 18.2-positive gastric cancers. Givastomig has the potential to treat other solid tumors.

I-Mab traded below US$1 for much of the year before getting a boost in Q3 from positive news flow.

On June 26, the company announced positive data from a Phase 1b study evaluating givastomig in combination with nivolumab and mFOLFOX6 chemotherapy for metastatic gastric cancers. This included a strong objective response rate and favorable safety profile. A few days later, it shared the publication of the first-in-human monotherapy data for givastomig in Clinical Cancer Research, a journal of the American Association for Cancer Research.

On July 17, I-Mab signed a definitive agreement to acquire 100 percent ownership of Bridge Health Biotech. This will give I-Mab the rights to bi-specific and multi-specific applications based on the Claudin 18.2 parental antibody used in givastomig. I-Mab expects to present a topline readout of its Phase 1b dose expansion in Q1 2026.

Shares of I-Mab hit a year-to-date high of US$3.37 on August 5.

3. Galectin Therapeutics (NASDAQ:GALT)

Year-to-date gain: 180.92 percent
Market cap: US$232.91 million
Share price: US$3.68

Galectin Therapeutics is developing therapies for patients with chronic liver disease and cancer.

The clinical-stage biopharma company’s lead drug candidate, carbohydrate-based belapectin, targets multiple inflammatory, fibrotic and malignant diseases by inhibiting the galectin-3 protein.

Belapectin has been granted fast-track designation by FDA. Galectin’s lead development program, the NAVIGATE Phase 2b/3 trial, is evaluating the efficacy and safety of using belapectin intravenously in patients with metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis and portal hyper tension.

In May, the company presented positive topline data from the study at the European Association for the Study of the Liver 2025 Congress. Results included a significant reduction in new esophageal varices at 18 months and fewer patients experiencing worsening liver stiffness, demonstrating potential to halt the progression of MASH cirrhosis.

In early July, Galectin announced a US$10 million unsecured line of credit facility with its largest individual stockholder and board chair, Richard E. Uihlein. It is expected to fund development work through June 2026.

Galectin’s share price peaked at US$3.68 on August 5.

4. CytomX Therapeutics (NASDAQ:CTMX)

Year-to-date gain: 136.63 percent
Market cap: US$375.74 million
Share price: US$2.38

CytomX Therapeutics is a clinical-stage biopharma firm with a focus on developing safer, more effective oncology treatments. It collaborates with a number of leading oncology firms, including Amgen (NASDAQ:AMGN), Bristol-Myers Squibb (NYSE:BMY), Regeneron Pharmaceuticals (NASDAQ:REGN) and Moderna (NASDAQ:MRNA).

The company’s pipeline is based on its PROBODY therapeutic platform, which it uses to produce localized biologics that target tumors. This includes multiple treatment modalities such as antibody-drug conjugates, T-cell engagers and immune modulators such as cytokines. Its clinical-stage pipeline includes CX-2051 and CX-801.

CytomX kicked off 2025 at US$1.06, but spent much of the first two quarters on a slow slide to a year-to-date low of US$0.43 on April 7. The stock shot up to US$2.50 on May 13 after a series of announcements.

The day prior, CytomX provided its first quarter business update, which included positive interim clinical results for an ongoing Phase 1 dose escalation study of its lead candidate, CX-2051, in advanced colorectal cancer.

The company has initiated further Phase 1 dose expansions, with data expected out by Q1 2026. CytomX’s goal is to initiate a Phase 2 study in advanced colorectal cancer in the first half of 2026.

At the same time, the company closed on a US$100 million underwritten offering of common stock.

On May 19, the first patient was dosed in CytomX’s ongoing Phase 1 dose escalation study with CX-801 in combination with Merck & Company’s (NYSE:MRK) KEYTRUDA (pembrolizumab) in patients with metastatic melanoma.

Shares of CytomX hit a year-to-date high of US$2.99 on June 12.

5. Gossamer Bio (NASDAQ:GOSS)

Year-to-date gain: 129.21 percent
Market cap: US$475.2 million
Share price: US$2.16

Gossamer Bio is focused on the development and commercialization of therapies to treat pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.

The clinical-stage biopharma company’s lead drug candidate, seralutinib, is currently being evaluated in a Phase 3 clinical trial for the treatment of pulmonary arterial hypertension.

Gossamer Bio’s stock value received a bump from US$1.30 to US$1.45 on March 14.

The day prior, the company shared a business update, including news that a topline data readout for its Phase 3 study of seralutinib in pulmonary arterial hypertension was on track for the fourth quarter of 2025.

On June 16, Gossamer Bio announced it had completed enrollment for an ongoing Phase 3 study on pulmonary arterial hypertension, with topline data expected out in February 2026.

On August 5, the company reported that it expects to activate the first clinical sites for a global registrational Phase 3 study on pulmonary hypertension associated with interstitial lung disease patients in Q4 2025.

Shares of Gossamer Bio hit a year-to-date high of US2.16 on August 5.

Securities Disclosure: I, Melissa Pistilli, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Keep Reading
By
Investing

Brien Lundin: Gold at New US$3,000 Floor, Silver Supply Crunch Coming

Brien Lundin, editor of Gold Newsletter, shares his thoughts on gold and silver prices, as well as what types of stocks he’s focusing on in these sectors.

In his view, the precious metals are set up for a new era.

Click here to sign up for the New Orleans Investment Conference, hosted by Lundin.

Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Keep Reading
By
Investing

Brunswick Exploration Consolidates Mirage Ownership

Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; FRANKFURT:1XQ; ‘ BRW ‘ or the ‘ Company ‘) is pleased to announce the consolidation of its ownership covering a group of eight mining claims at the Mirage project pursuant to a purchase and sale agreement dated August 15, 2025, with General Partnership Osisko Baie James (‘Osisko Baie James’). Brunswick Exploration now owns 100% of the mining claims across the Mirage project.

To acquire such rights, Brunswick has agreed to renounce to its option to acquire a 90% undivided interest in the Plex property, pursuant to the third amendment to option agreement, dated August 15 2025, between Brunswick and Osisko Baie James.

In partial consideration for the termination of the Plex Property Option pursuant to this Third Amendment Agreement, Osisko Baie James shall pay to Brunswick Exploration an amount of $1,000,000 to be paid within thirty (30) days of the first publication of a technical report prepared in accordance with the requirements of Regulation 43-101 presenting a minimum of 1M oz in gold in Measure, Indicated and/or Inferred resources (as those terms are defined in National Instrument 43-101).

Grant of DSU

The Corporation announces that it has granted 821,425 deferred share units (‘DSUs’) to its non-executive directors, in accordance with the Corporation’s Deferred Share Unit Plan, available on SEDAR+ at www.sedarplus.ca. in lieu of their board fees. The DSUs were granted at a fair market value of $0.14 per DSU and will vest one year from the grant date.

About Brunswick Exploration

Brunswick Exploration is a Montreal-based mineral exploration company listed on the TSX-V under symbol BRW. The Company is focused on grassroots exploration for lithium in Canada, a critical metal necessary to global decarbonization and energy transition. The company is rapidly advancing its extensive grassroots lithium property portfolio in Canada and Greenland.

Investor Relations/information

Mr. Killian Charles, President and CEO ( info@BRWexplo.com )

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release

Cautionary Statement on Forward-Looking Information

This news release contains ‘forward-looking information’ within the meaning of applicable Canadian securities legislation based on expectations, estimates and projections as at the date of this news release. Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, delays in obtaining or failures to obtain required governmental, environmental or other project approvals; uncertainties relating to the availability and costs of financing needed in the future; changes in equity markets; inflation; fluctuations in commodity prices; delays in the development of projects; the other risks involved in the mineral exploration and development industry; and those risks set out in the Corporation’s public documents filed on SEDAR at www.sedar.com. Although the Corporation believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Corporation disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

News Provided by GlobeNewswire via QuoteMedia

This post appeared first on investingnews.com

Keep Reading
By
Investing

Westport Files Preliminary Short Form Base Shelf Prospectus To Replace Expired Base Shelf Prospectus

Westport Fuel Systems Inc. (‘Westport’) (TSX: WPRT Nasdaq: WPRT) announces it has filed a preliminary short form base shelf prospectus (once filed in final form and received by the relevant Canadian securities regulatory authorities, the ‘Shelf Prospectus’) with the securities commissions in each of the provinces and territories of Canada, to replace its prior base shelf prospectus that expired on June 18, 2025.

The Shelf Prospectus, when made final, will allow Westport to offer up to USD$100,000,000 of common shares, preferred shares, subscription receipts, warrants, debt securities, or units, or any combination thereof (collectively, the ‘Securities’) during the 25-month period that the Shelf Prospectus will be effective. The Shelf Prospectus will enable Westport to access new capital or issue securities in connection with strategic acquisitions if and when needed. The amount and timing of any future offerings or issuances will be based on the Company’s financial requirements and market conditions at that time.

Westport has also filed a corresponding shelf registration statement relating to the Securities with the United States Securities and Exchange Commission (‘SEC’) on Form F-3 (the ‘Registration Statement’).

The specific terms of any future offering or issuance under the Shelf Prospectus and Registration Statement will be established at the time of such offering. There are currently no offerings or issuances planned under these filings. At the time any of the Securities covered by these filings are offered for sale, a prospectus supplement containing specific information about the terms of such offering will be filed with applicable Canadian securities regulatory authorities and the SEC.

The Registration Statement has been filed with the SEC but has not yet become effective. The Securities may not be sold, nor may offers to buy be accepted, prior to the issuance of a receipt for the final Shelf Prospectus and the time the Registration Statement becomes effective. This news release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which an offer, solicitation or sale would be unlawful prior to registration or qualifications under the securities laws of any such jurisdiction.

A copy of the preliminary short form base shelf prospectus can be found on SEDAR+ at www.sedarplus.ca and a copy of the corresponding shelf registration statement is available on EDGAR at www.sec.gov.

About Westport Fuel Systems

Westport is a technology and innovation company connecting synergistic technologies to power a cleaner tomorrow. As a leading supplier of affordable, alternative fuel, low-emissions transportation technologies, we design, manufacture, and supply advanced components and systems that enable the transition from traditional fuels to cleaner energy solutions.

Our proven technologies support a wide range of clean fuels – including natural gas, renewable natural gas, and hydrogen – empowering OEMs and commercial transportation industries to meet performance demands, regulatory requirements, and climate targets in a cost-effective way. With decades of expertise and a commitment to engineering excellence, Westport is helping our partners achieve sustainability goals—without compromising performance or cost-efficiency – making clean, scalable transport solutions a reality.

Westport Fuel Systems is headquartered in Vancouver, Canada. For more information, visit www.westport.com .

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking information within the meaning of applicable securities laws in Canada and forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, as amended (collectively referred to as, ‘forward-looking statements’) that are based on our management’s beliefs and assumptions and on information currently available to our management. You can identify forward-looking statements by terms such as ‘may’, ‘would’, ‘could’, ‘will’, ‘intend’, ‘plan’, ‘anticipate’, ‘believe’, ‘estimate’, ‘expect’, ‘project’ and similar expressions, as they relate to us or our management. The forward-looking statements contained in this press release include, but are not limited to, statements regarding the offer or issuance of securities.

We refer potential investors to the ‘Risk Factors’ section of our annual information form dated March 31, 2025 available on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov as an exhibit to our report on Form 40-F dated March 31, 2025 under Westport’s public filings for additional risks regarding the conduct of our business and Westport. The reader is cautioned to consider these and other risks and uncertainties carefully and not to put undue reliance on forward-looking statements. Forward-looking statements reflect current expectations regarding future events and speak only as of the date of this press release and represent our expectations as of that date.

We undertake no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise, except as may be required by applicable law.

Investor Inquiries:
Investor Relations
T: +1 604-718-2046
E: invest@Westport.com

News Provided by GlobeNewswire via QuoteMedia

This post appeared first on investingnews.com

Keep Reading
By
Investing

Element79 Gold Corp Announces Corporate Update and Strategic Leadership Changes With Focus On Accelerating Nevada Asset Development

(TheNewswire)

Vancouver, BC August 15, 2025 TheNewswire – Element79 Gold Corp. (CSE: ELEM,OTC:ELMGF | FSE: 7YS0 | OTC: ELMGF) (the ‘Company’), is a Canadian mining company focused on developing its portfolio of gold and silver projects in Nevada and Peru, announces strategic leadership changes which will be effective August 31, 2025, alongside an update on its advancing growth strategy.

Key Highlights Discussed:

Advancing Lucero, Peru – Continued incubation of the high-grade Lucero Project in southern Peru, with a mid-long-term objective of restarting exploration and production.

  • Leadership Transition – Effective August 31, 2025, including strategic changes to both Management and the Company’s Board of Directors, with the goal of accelerating asset development in Nevada.

Corporate Strategy Update

Nevada

Over the past year, Element79 Gold has sharpened its focus on building a long-term exploration and development portfolio in Nevada , anchored by the recent acquisition of the drill-ready Gold Mountain project and plans to explore the Elephant project, both located in the prolific Battle Mountain trend.  The Company has had success in developing projects in this Tier 1 mining region in the past, and this refocused strategy forms the foundation for the Company’s next phase of resource growth, positioning Element79 in one of the world’s most established gold districts. The Company currently has two projects in Battle Mountain, Nevada:

  • Gold Mountain , a Drill-ready asset with near-term exploration plans aimed at expanding known mineralization and advancing toward resource definition. The Company has engaged Rangefront Mining Services to prepare a NI 43-101 technical report as disseminated on August 6, 2025, in previous news.

  • Elephant Located in the heart of the Battle Mountain trend, targeted for systematic exploration to evaluate and advance its Gold, Silver, Lead and Copper potential.

The Company is currently pursuing additional high grade mineral concessions in the region to add to its evolving portfolio.

Peru

At the same time, the Company continues to incubate its high-grade Lucero Project in Arequipa, Peru , preparing for the eventual restart of exploration and production. Work in Peru is currently focused on community engagement, legal and regulatory readiness, and aligning future project development for win-win outcomes with key stakeholders with an eye to the access issues being resolved in the coming months.

Key project points for Lucero into 2026:

  • Maintain regular communication and presence in the Chachas community, anticipating a more favorable local administration beginning in 2026–2028 (local meetings starting at the end of August 2025 will focus on the local mayoral race).

  • Monitor federal updates to the ‘systemic push’ towards formalization under the former-REINFO-to-new-Ley MAPE transition, with a key catalyst deadline of December 31, 2025, approaching.

  • Upon the implementation of the new formalization regime, working with legal counsel and the community to forge surface rights and operating agreements.

  • Target mobilization for on-site work in mid-2026, contingent on formalization progress and community agreements.

  • Work with contractual counterparties to restructure terms, linking payments to mutually beneficial project advancement and production goals.

Leadership and Board Changes

Effective August 31, 2025:

  • James C. Tworek , Chief Executive Officer since inception, has elected to step down from the role and continue to support the Company as a Director.

  • Michael Smith , currently Vice President, Corporate Development, will be appointed Chief Executive Officer.

  • Neil Pettigrew will resign as Director and Qualified Person (‘QP’).  The Company is grateful for Mr. Pettigrew’s investment of expertise and help applied through the Company’s history from inception.

  • Kim Kirkland , currently Chief Operating Officer, will formally take on the Company’s QP role and join the Board of Directors, while stepping down from his role as COO.

  • Warren Levy will remain as Director and will assume the role of Chairman of the Board.

  • Zara Kanji will continue as Director.

Outgoing CEO James C. Tworek commented:

‘It has been a privilege to build, grow and lead the talented team professionals at Element79 Gold from its private company roots through multiple transformative milestones and successes since our IPO in August 2021.  These changes to the Element79 Gold Corp team make the Company nimbler while retaining expertise, intimate project knowledge and relationships.

We are grateful for our Director, Neil Pettigrew’s leadership and expertise with the Company’s multitude of projects, and guidance through many challenges that we have faced, both before and since our IPO.  I wish him success in his current and future professional endeavors and look forward to the possibility to work with him again.

With the Company’s recent refocus on exploration and resource development in Nevada while continuing a mid-to-long term strategy of restarting production at Lucero in Peru, I am confident that Michael is the right leader to guide the current phase of growth.  I remain committed to supporting the Company, helping to manage strategy, relationships and projects as a board member.’

Incoming CEO Michael Smith added:

‘I am honored and excited to take on the role of CEO during this exciting time of refocus and development opportunity underway at Element79 Gold Corp. Our immediate priorities lead a raise focused on drilling Gold Mountain, developing Elephant and maintaining momentum at Lucero in Peru.  I look forward to building upon the strong foundation laid by James and the team.’

Warren Levy, Chairman added:

‘I would like to thank James and Neil for their efforts over the years to keep Element79 moving forward, and am looking forward to Michael taking the lead going forward. The refocused company has an attractive portfolio and has maintained access to the upside in Peru. We feel that the hard work of positioning the company has been well done by James and Kim, and their continued involvement on the board will be important to assist the new management team in taking the company forward successfully.’

Qualified Person

The technical information in this release has been reviewed and approved by Kim Kirkland, Fellow of AusIMM #309585, Chief Operating Officer of Element79 Gold Corp, and a ‘qualified person’ as defined by National Instrument 43-101.

About Element79 Gold Corp

Element79 Gold Corp is a mining company focused on gold and silver exploration, with assets in Nevada and Peru. The Company is actively advancing its drill-ready Gold Mountain Project in Nevada’s Battle Mountain trend and holds an option to purchase the high-grade Lucero Mine in southern Peru. Element79 has transferred its Dale Property in Ontario to its wholly owned subsidiary, Synergy Metals Corp., and is progressing through the spin-out process. Element79 Gold is listed on the CSE (CSE: ELEM,OTC:ELMGF), the Frankfurt Stock Exchange (FSE: 7YS0), and the OTC Markets (OTC: ELMGF).

On Behalf of the Board of Directors,

James C. Tworek, CEO, Director

Investor Relations Department

Email : investors@element79.gold

Phone : +1.604.319.6953

Corporate Contact

James Tworek, CEO, Director

Email: jt@element79.gold

Cautionary Note Regarding Forward Looking Statements

This press release contains forward-looking statements within the meaning of applicable securities laws. The use of any of the words ‘anticipate,’ ‘plan,’ ‘continue,’ ‘expect,’ ‘estimate,’ ‘objective,’ ‘may,’ ‘will,’ ‘project,’ ‘should,’ ‘predict,’ ‘potential’ and similar expressions are intended to identify forward-looking statements. This press release contains forward-looking statements concerning the Company’s exploration plans, development plans and the Force Majeure Event. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on these statements because the Company cannot provide assurance that they will prove correct. Forward-looking statements involve inherent risks and uncertainties, and actual results may differ materially from those anticipated. Factors that could cause actual results to differ include conditions in the duration of the Force Majeure Event, and receipt of regulatory and shareholder approvals. These forward-looking statements are made as of the date of this press release, and, except as required by law, the Company disclaims any intent or obligation to update publicly any forward-looking statements.

Neither the Canadian Securities Exchange nor the Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Copyright (c) 2025 TheNewswire – All rights reserved.

News Provided by TheNewsWire via QuoteMedia

This post appeared first on investingnews.com

Keep Reading
By
Investing

OPINION — Goldenomics 103: Gold Protects and Performs

By Darren Brady Nelson

US President Donald Trump’s “Liberation Day” tariffs certainly caused quite the stir in the markets on April 2.

Gold dropped about 6 percent, and silver 12 percent. A week later, a pause was announced, which ended on August 1. Gold and silver have since risen approximately 11 percent and 24 percent, respectively.

Six month gold and silver price performance.

Source: Trading Economics (gold) and (silver).

Unless you are a professional, or even amateur, trader, it is best to look at gold and silver investment with a perspective of years or decades, rather than just days, weeks or even months. Since the start of the COVID-19 panic in March 2020, gold and silver have exploded 123 percent and 192 percent.

10 year gold and silver price performance.

Source: Trading Economics (gold) and (silver).

In the shorter term, the gold price is driven by what economist John Maynard Keynes called “animal spirits.” In the longer term, it is driven by “monetary spirits.” And not just as protection, but also for performance. The Presidential Gold Guide highlights both in chapters four and five.

Source: Fisher Liberty Gold.

Gold unsurprisingly protects

Economist and investor Mark Skousen has wisely noted that: “Since we left the gold standard in 1971, both gold and silver have become superior inflation hedges.” Gold has more than countered the results of inflation, as measured by CPI, and the drivers of inflation, as measured by M3.

And the numbers back that up. The Gold Protects chart below compares the gold price, CPI and M3 in terms of cumulative growth of each from 1971 to 2025. That is throughout the whole era of gold as an investment, which officially started in 1974 once private ownership was restored.

During this era, gold grew by 541 percent, CPI by 214 percent and M3 by 384 percent. Annual average growth for gold was 10 percent, CPI at 4 percent and M3 at 7 percent. Maximums were 92 percent, 14 percent and 29 percent, respectively. CPI only failed to grow twice, ie. 0 percent in 2009 and 2015. M3 decreased twice, by -4 percent in 2023 and -6 percent in 2024.

Sources: FRED (CPI) (M3); World Bank (gold).

Gold surprisingly performs

The highly respected In Gold We Trust (IGWT) report states: “When dealing with the specific level of gold allocation, it is advisable to differentiate between safe-haven gold and performance gold. The Big Long strategy emphasizes the potential of performance gold in the coming years.”

IGWT thus recommends an investment portfolio ‘rule of thumb’ that includes 15 percent in “safe-haven gold” and 10 percent in “performance gold.” The Gold Performs chart below compares gold price, S&P 500 and nominal GDP in terms of cumulative growth of each from 1971 to 2025.

Gold grew by 541 percent, the S&P 500 by 484 percent and GDP by 339 percent. Annual average growth for gold was 10 percent, with the S&P 500 at 9 percent and GDP at 6 percent. Maximums were 92 percent, 45 percent and 14 percent, respectively. Gold did have a higher standard deviation of 27 percent, compared to 17 percent for the S&P 500 and 3 percent for GDP.

Sources: FRED (GDP); Shiller Data (S&P); World Bank (gold).

Animal and monetary spirits

Gold protects as a hedge or safe haven, not just from inflation, but from the flip side of that same coin of the boom-bust cycle. Both are driven, in the longer term, not by “animal spirits,” but by “monetary spirits.”

Inflation is when money inflation has a widespread impact as price inflation. A bubble is when money increases have a more concentrated impact such as in certain asset values. The bubble eventually bursts when “monetary spirits” are finally reined in by monetary realities.

I say “monetary spirits” because of the role of fiat money, as indicated by, say, M3. When money supply outstrips money demand in a localized way, then that is a bubble, and when in a general way, that is inflation.

The former shows up in certain asset, wholesale and/or producer prices, whilst the latter shows up in CPI. Asset prices include the S&P 500. But nominal GDP is also ‘ginned up’ as it is ultimately a price times quantity measure as well. Price is expressed in money terms.

Conclusion

Gold can have ups and downs, as standard deviation indicates, due to the “animal spirits” of fear and uncertainty, that tend to be daily, weekly or monthly. Yet gold both protects and performs due to the “monetary spirits” of inflation and boom-bust, which tend to be decennially.

In particular, gold performs when the S&P 500 does not, like in the aftermaths of the 2001/2002 dot-com collapse, the 2008/2009 global financial crisis and 2020/2021 COVID-19 lockdowns.

Therefore, when it comes to gold, “follow the money” of central bank “money printing” and fractional reserve bank “fountain pen money,” for both superior inflation protection and boom-bust performance.

And besides, Skousen rightly ‘begged the question’ as follows: “Gold and Silver have always had value, never gone to zero. Can you say the same for stocks and bonds?”

About Darren Brady Nelson

Darren Brady Nelson is chief economist with Fisher Liberty Gold and policy advisor to The Heartland Institute. He previously was economic advisor to Australian Senator Malcolm Roberts. He authored the Ten Principles of Regulation and Reform, and the CPI-X approach to budget cuts.

Click here to read Goldenomics 101: Follow the Money, and here to read Goldenomics 102: The Shadow Price of Gold.

This post appeared first on investingnews.com

Keep Reading
By
Investing

Editor’s Picks: Gold Tariff Threat Ends, Price Reacts to Fresh Inflation Data

The gold price cooled off this week as tariff-related uncertainty reached a resolution.

The yellow metal was thrust into headlines late last week when US Customs and Border Protection told a Swiss refiner that 1 kilogram and 100 ounce gold bars would be subject to Trump administration tariffs that went into effect on August 7.

Gold is one of Switzerland’s top exports to the US, and with the country facing a 39 percent levy, questions were rife about what the impact could be. Clarification came on Monday (August 11), when US President Donald Trump said on Truth Social that gold ‘will not be tariffed.’

While the news calmed market participants, Keith Weiner of Monetary Metals believes the incident could have long-term impacts. He said the tariff confusion caused the spread between spot gold and gold futures to blow out, creating difficulties for entities using the market to hedge.

Here’s how Weiner explained it:

‘Once you’ve put the scare into everybody, you can’t just say, ‘Oh, sorry, just kidding.’ You can’t really do that. And so now we’ve done damage, and we’ll see what happens to that spread over time. We’ll see how users of the futures market adapt.

‘There are other markets in the world that would be competing for this hedging business — maybe it moves to Singapore, maybe it moves to Dubai, maybe it moves to London, and the US loses not only a little more trust, but also a little bit of volume on what had been the biggest, or what is currently the biggest, futures market.’

This week also brought the release of US consumer price index (CPI) and producer price index (PPI) data. On a seasonally adjusted basis, CPI for July was up 0.2 percent from the previous month and 2.7 percent from the year-ago period. Meanwhile, core CPI, which excludes the food and energy categories, was up 0.3 percent month-on-month and 3.1 percent from the same time last year.

While those numbers were largely in line with expectations, seasonally adjusted July PPI figures came in hotter than expected, rising 0.9 percent month-on-month compared to Dow Jones’ forecast of 0.2 percent. Core PPI increased 0.9 percent from June compared to an estimated rise of just 0.3 percent.

Speaking about the implications of the data, Danielle DiMartino Booth of QI Research said it shows companies aren’t yet passing tariff-related price increases on to consumers.

This is what she said about how these circumstances could develop:

‘I do think that we will see where companies feel they can push through price increases — I think we’ll see that. We saw quite a bit of food inflation in the PPI, and when you’re talking about things like essentials, and especially with very, very low-margin types of sales, we could see what we call the substitution effect begin, where households end up buying other things. The classic is always that they trade down from steak to ground beef, or trade down from beef to chicken.

‘We’re going to see whether or not that plays out again.’

While the PPI data has slightly dampened expectations that the US Federal Reserve will cut interest rates when it meets in September, CME Group’s (NASDAQ:CME) FedWatch tool still shows a strong probability of a reduction at that time.

Bullet briefing — CATL closes mine, Mitsubishi invests in copper

CATL temporarily closes lithium mine

Contemporary Amperex Technology (HKEX:3750,SZSE:300750), better known as CATL, said on Sunday (August 10) that it will halt production at a lithium mine in China for at least three months.

Sources familiar with the matter told Bloomberg that CATL, which is the world’s largest electric vehicle battery maker, failed to extend a key mining permit. The company is reportedly in talks about a renewal, but is prepared for a months-long shutdown.

Share prices of lithium miners rose on the news, buoyed by expectations that the CATL mine closure will help reduce oversupply. Excess output has caused Chinese lithium prices to drop 80 percent since the end of 2022, and investors are keen to see a turnaround for the beleaguered battery metal.

Hudbay, Mitsubishi team up on copper

Mitsubishi (TSE:8058) is set to acquire a 30 percent stake in Hudbay Minerals’ (TSX:HBM,NYSE:HBM) Arizona-based Copper World subsidiary for US$600 million.

Hudbay called Mitsubishi its ‘strategic partner of choice,’ while Mitsubishi said the investment will help advance its copper growth plans. A feasibility study is in the works for Copper World, and a definitive feasibility study is expected in mid-2026.

Hudbay shareholders reacted positively to the news, which comes on the back of a strong focus on copper supply after last month’s announcement of a 50 percent tariff on US imports of semi-finished copper products and intensive copper derivative products. The company projects that Copper World will result in a direct $1.5 billion investment into the US critical minerals supply chain.

Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Keep Reading
By